Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription
NF-κB / AP-1 Transcriptional Blockade · Immune recognition and inflammatory cascade control
Suppresses IKK kinase phosphorylation and IκB ubiquitination and degradation, stops p65/p50 heterodimers from entering the nucleus, and cuts off expression of TNF-α, IL-6, IL-1β and similar mediators.
Supplements acting on this mechanism (ranked by strength and evidence)
Trans-resveratrol
Randomized human trials at usual doses observed lower NF-κB activity, but results differ across populations and markers. The upstream mechanism of this effect has not been established, and the finding does not show that SIRT1 directly deacetylates NF-κB p65.
Curcumin
In experimental models, curcumin can inhibit IKK and NF-κB signaling. In patients with advanced pancreatic cancer taking 8 g daily, NF-κB expression in peripheral blood mononuclear cells fell. However, the direct target and transcriptional activity inside the cell nucleus at usual doses have not been confirmed.
Quercetin
Quercetin can inhibit NF-κB signaling in some animal and cell models, reducing p65 nuclear translocation. After usual oral dosing, the circulating form is mainly conjugated metabolites. There is no direct evidence on whether p65 nuclear translocation is blocked in humans.
Palmitoylethanolamide (micronized PEA)
PEA can activate PPAR-α. In mice lacking PPAR-α, some of its anti-inflammatory effects were lost. In inflamed rat tissue, NF-κB signaling also decreased somewhat. Whether routine oral doses can reach enough receptor occupancy in target tissue to produce measurable NF-κB inhibition has not been confirmed in humans.
Luteolin
In cell and mouse studies, luteolin can suppress IκBα and NF-κB signaling and reduce transcription of inflammatory factors. Inhibition of central IKK and STAT3 has only been seen in experimental models, and whether it happens in the human brain has not been tested.
Natural full-spectrum tocotrienols
In cell studies, γ- and δ-tocotrienols can inhibit IκBα phosphorylation, and animal studies at higher doses also found changes in NF-κB signaling. Whether this target is inhibited in humans has not been measured, and general inflammation markers cannot stand in for that measurement.
Ginger extract (gingerol / shogaol)
Ginger components can modulate NF-κB signaling in cell and animal experiments, but specific targets such as p65 alkylation have not been confirmed in humans. After oral intake, exposure to free gingerol is limited by conjugative metabolism, and its effect in human mucosa has not been determined.
Andrographolide
The unsaturated lactone ring of andrographolide can covalently modify cysteine 62 of the NF-κB p50 subunit, inhibiting its activation in cell and animal experiments. Whether this target is occupied in humans has not been measured directly, and the extent of modification after oral dosing is uncertain.
Piperlongumine
In mice, intraperitoneal piperlongumine can suppress NF-κB signaling in the brain after an inflammatory stimulus, which is a different exposure from oral supplementation. No reliable study has examined whether it suppresses the inflammatory factors secreted by senescent cells (SASP) in humans.
Methylsulfonylmethane (MSM / OptiMSM)
In mice given MSM orally, higher doses lowered NF-κB expression and inflammatory markers in stomach tissue. This comes from an animal model with a specific dose and tissue. It cannot be taken to mean that usual oral doses block IκBα or lower cytokines in human cartilage.
Kushen extract (oxymatrine / matrine)
In an animal cerebral ischemia model, oxymatrine downregulated TLR4, MyD88 and NF-κB-related expression in brain tissue. In cell experiments, nuclear translocation of p65 decreased. In mice, colitis was reduced, but the overall NF-κB reporter signal did not change. These results do not yet show that it strongly shuts off inflammatory transcription at usual oral doses in humans.
N-acetylcysteine (NAC)
Under specific strenuous exercise stress, a randomized double-blind crossover trial in humans found reduced NF-κB phosphorylation in skeletal muscle. This is a secondary effect under that particular stress and does not mean NAC broadly suppresses inflammation.
High-potency omega-3 (EPA/DHA, SPM precursors)
Omega-3 can modulate the FFAR4 receptor and downstream inflammatory signaling. Small human studies measured changes in the upstream receptor and related genes. However, the full chain from GPR120 to NF-κB inhibition has not been shown in humans, and whether NF-κB nuclear translocation is suppressed has not been directly confirmed.
Sulforaphane
In experimental models, sulforaphane can reduce NF-κB binding to DNA. This may be related to cysteine modification of p65. The specific modification sites in humans have not been confirmed, and reliable pathway inhibition has not been directly measured after usual oral doses.
Berberine
In animal and cell inflammation models, berberine can inhibit TLR4 and NF-κB signaling and reduce the release of pro-inflammatory factors. Pathway inhibition after oral intake in humans has not been directly confirmed, and human cell experiments with berberine added in vitro are not equivalent to oral trials.
Fisetin
In some animal models of inflammation, fisetin can reduce p65 nuclear entry and DNA binding. A drop in pro-inflammatory SASP factors does not by itself prove that NF-κB was inhibited, and the effect on this pathway in humans after usual oral doses is not yet clear.
Natural astaxanthin
In experiments in diabetic rats and in macrophages, astaxanthin can reduce NF-κB-related signaling. There is currently no reliable evidence on whether usual oral doses directly inhibit NF-κB activity in humans.
Diindolylmethane (DIM)
In cell and mouse experiments, DIM can inhibit NF-κB activation and reduce brain inflammation. Related pathway changes were also seen in animal lung tissue. No reliable trial has directly shown whether NF-κB activity changes in humans after standard oral DIM.
Apigenin
Animal studies support the idea that apigenin suppresses NF-κB-related SASP pro-inflammatory signaling. Its pathway effects in human tissue after oral dosing are unclear, and this mechanism currently rests mainly on cell and animal work.
Natural lycopene
Animal studies show lycopene can reduce hepatic NF-κB phosphorylation, and in cell studies it can also dampen TNF-α-induced ICAM-1 and NF-κB signaling. Whether NF-κB is inhibited in human vascular endothelium or tissue has not been directly confirmed.
Urolithin A
In a sleep-deprivation mouse model, urolithin A reduced NF-κB- and NLRP3-related signaling in the hippocampus. Changes in human inflammatory markers cannot by themselves prove NF-κB inhibition. The cGAS–STING and NLRP3 pathways are also not the same thing as NF-κB, and human evidence is still insufficient.
Black cumin seed oil extract (thymoquinone)
A mouse study showed that oral thymoquinone can reduce phosphorylation of p65 and IκBα in inflamed tissue, which suggests some modulation of the NF-κB pathway. This result comes from an animal model, and an effect in humans at routine oral exposure has not yet been confirmed.
D-glucosamine sulfate 2KCl
In a mouse dietary study, glucosamine sulfate reduced NF-κB-related expression in a colitis model. The findings on inhibiting nuclear translocation of NF-κB p65 in chondrocytes come mainly from experimental models and have not been confirmed in human joints at usual oral doses.
Conjugated linoleic acid (CLA / Tonalin c9,t11 & t10,c12)
In animal studies, CLA can downregulate NF-κB-related signaling under some conditions, but the direction of the inflammatory effect differs between isomers. Neither the claim that c9,t11 is a weak PPAR-γ agonist nor a fall in TNF-α is enough on its own to prove that NF-κB is inhibited in humans.
Boswellia extract (acetyl-11-keto-beta-boswellic acid, AKBA)
Findings of direct inhibition of IκB kinase (IKK) and blocking of NF-κB entry into the nucleus come mainly from in-vitro experiments at micromolar concentrations, and from cell and animal models. It is unclear whether free AKBA reaches effective concentrations at usual doses, and inflammation outcomes in humans cannot show that this target is responsible.
L-ergothioneine (MitoPrime)
Cell studies suggest that L-ergothioneine can modulate NF-κB/p65-related inflammatory responses, and bone protection was seen in animal oral studies. However, a drop in inflammatory mediators does not equal NF-κB inhibition, and the effect at usual human doses is not established.
Glycine + NAC complex (GlyNAC)
In cell studies, NAC can inhibit NF-κB activity under inflammatory stimulation. Human trials reported changes in inflammatory markers such as hs-CRP and TNF-α, but these markers cannot show that NF-κB was inhibited. The combination’s effect on this pathway in humans has not been directly confirmed.
Boron
Some human studies observed changes in inflammatory markers after boron supplementation, and high-dose animal experiments also showed lower NF-κB-related markers. However, changes in inflammatory markers do not prove that NF-κB is inhibited. It is also unclear whether a typical 3–10 mg elemental boron dose produces the same effect.
Lifestyle practices acting on this mechanism (ranked by strength and evidence)
Mediterranean diet
A small randomized crossover study found lower NF-κB activation in monocytes during a Mediterranean diet than during a Western diet rich in saturated fat. Whether this change brings clinical benefit has not been confirmed.